Citi18 Jul 2022 19:16
Thought I'd re-post the page 1 of the 62 page Citi broker note Xavik posted:
A Beast in Beauty
CITI'S TAKE
Amid M&A newsflow, commodities/FX driven downgrades, corporate
governance debates and questions over THG Ingenuity, we feel the market
is underestimating the value of THG Beauty division, which is a very strong
player in a very attractive market and, alone, could make up for the total
valuation of the company. Following a period of restriction we are resuming
coverage with a Buy Rating, targeting 220p (c. 200% upside).
A Beast in Beauty — We assess the strategic dynamics of the Beauty online retail
market and we find a very competitive environment where THG Beauty stands out,
with the best assortment in the market at the best price. Beauty brands’ push for more
Direct-to-consumer could imply more 3P (Third-Party) distribution going forward.
Even under this scenario, which should improve margins and lower the capital
intensity of the business, we’d expect THG Beauty to remain a leader, thanks to its
strong relationship with beauty brands and logistics capabilities.
Negative newsflow in the rear view mirror? — THG shares are down > 80% over
the last 12months amid a tech/growth market sell-off and further penalized by
commodities (whey) and currencies (GBP/JPY) driven downgrades. With whey prices
and JPY starting to move in the right direction, we expect gross margin recovery to
drive back margins normalization to 9% by FY25e. In addition, the recent appointment
of a new non-executive Chairman should ease concerns on corporate governance.
Mark-to-market drives 220p TP- c.200% upside — We think the recent M&A
interest in THG highlights the clear value in the shares. Applying peer group multiples
and conservatively overlaying a 30% discount, we derive a SOTP-based target price
of 220p (c. 200% upside, vs 250p before), representing 1.2x FY23E EV/Sales. In our
bull case, analyzing the potential impact of THG’s divisional separation exercise and
considering our view of normalized/FY25E divisional FCF, our DCF-based SOTP
derives 600p/share. Our SOTP implies 2.0x FY23E EV/Sales for Beauty, 2.1x for
Nutrition and 3.1x for Ingenuity, [with the internal separation exercise improving the
capital efficiency of both Beauty and Nutrition]